back to Meetings page
- IMMPACT-VI
- June 3-4, 2005
- Willard InterContinental Hotel
- Washington, DC
Co-chairs:- Dennis C. Turk, PhD (University of Washington)
- Robert H. Dworkin, PhD (University of Rochester)
- Academia Participants
- Nicholas Bellamy, MD (University of Queensland)
- Charles S. Cleeland, PhD (MD Anderson Cancer Center)
- John T. Farrar, MD (University of Pennsylvania)
- Alejandro R. Jadad, MD, DPhil (University of Toronto)
- Nathaniel P. Katz, MD (Tufts University Medical School)
- Michael McDermott, PhD (University of Rochester)
- Patrick McGrath, PhD (Dalhousie University)
- Henry J. McQuay, MD (University of Oxford)
- Lemuel A. Moye, III, MD, PhD (University of Texas Health Science Center)
- Dennis A. Revicki, PhD (MEDTAP International)
- Government Participants
- Laurie B. Burke, RPh, MPH (US Food and Drug Administration)
- Sharon Hertz, MD (US Food and Drug Administration)
- Mitchell B. Max, MD (US National Institutes of Health)
- Thomas Permutt, PhD (US Food and Drug Administration)
- James Witter, MD, PhD (US Food and Drug Administration)
- Patient Representative
- Penney Cowan (American Chronic Pain Association)
- Industry Participants
- Julie Chandler, PhD (Merck & Company)
- Rozalina Dimitrova, MD, MPH (Allergan, Inc.)
- Joseph F. Heyse, PhD (Merck & Company)
- Smriti Iyengar, PhD (Eli Llly & Company)
- Gary W. Jay, MD (Schwarz Biosciences)
- John A. Jermano, RN, MPH (NeurogesX, Inc.)
- Donald C. Manning, MD, PhD (Celgene Corporation)
- Susan Martin, MSPH (Pfizer)
- Gwendolyn Niebler, DO (Cephalon, Inc.)
- Steven Quessy, PhD (GlaxoSmithKline)
- Margaret Rothman, PhD (Johnson & Johnson)
- Joseph W. Stauffer, DO (Alpharma)
- Ola Svensson, MD, PhD (Astra Zeneca)
- Richard E. White, PhD (Endo Pharmaceuticals)